Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes
- PMID: 1646640
- DOI: 10.1016/s0167-4889(97)90006-9
Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes
Abstract
In this study, we investigated the possibility that cultured keratinocytes from normal human adult skin produce 1,25-dihydroxyvitamin D-3 (1,25(OH)2D3, a biologically active form of vitamin D-3) from 25-hydroxyvitamin D-3 [25(OH)D3], and that 1,25(OH)2D3 endogenously produced by keratinocytes is involved in the self regulation of their growth and differentiation. To determine whether 1,25(OH)2D3 is produced from 25(OH)D3 by skin keratinocytes, 25(OH)[3H]D3 was added to keratinocyte cultures and incubated for 1 h and 5 h. The intracellular and extracellular metabolites were analyzed by three chromatographic systems. The three chromatograms revealed that the major metabolite produced from 25(OH)D3 was 1,25(OH)2D3. Most of the 1,25(OH)2D3 endogenously produced from 25(OH)D3 remained within the cells. To examine the time course of 1,25(OH)2D3 production, the amount of 1,25(OH)[3H]D3 was measured at 15 min, 1 h, 5 h and 10 h, being at a maximum 1 h after the addition of 25(OH)D3. These data indicate that keratinocytes rapidly convert 25(OH)D3 to 1,25(OH)2D3 and that 1,25(OH)2D3 is not released into the medium. To determine whether endogenously produced 1,25(OH)2D3 is involved in the regulation of growth and differentiation of normal human keratinocytes, we examined the effects of 1,25(OH)2D3 and 25(OH)D3 on their growth and differentiation. Keratinocyte growth was inhibited to 52.6% and 23.4% by 10(-8) M and 10(-7) M 1,25(OH)2D3 and to 80.5% and 23.9% by 10(-8) M and 10(-7) M 25(OH)D3, respectively. Differentiation of these cells was evaluated by quantifying the number which express involucrin, a precursor protein of cornified envelope. The population of involucrin expressing cells (differentiated cells) increased from 6.2% to 14.5% by 2.5.10(-7) M 1,25(OH)2D3, and to 11.8% by 2.5.10(-7) M 25(OH)D3. These results clearly indicate that 25(OH)D3 is as effective on human keratinocytes as 1,25(OH)2D3 in inhibiting growth and inducing differentiation, although to a slightly lesser extent than 1,25(OH)2D3. The possibility that the effect of 25(OH)D3 is mediated through binding to the 1,25(OH)2D3 receptor can be excluded, since a competitive binding assay revealed that the affinity of 25(OH)D3 for the 1,25(OH)2D3 receptor in a cytosolic extract of keratinocytes was 100-times lower than that of 1,25(OH)2D3. Thus, these results suggest that 1,25(OH)2D3 endogenously produced in keratinocytes from 25(OH)D3 is involved in the regulation of their growth and differentiation in vitro.
Similar articles
-
Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes.J Dermatol. 1990 Feb;17(2):97-103. doi: 10.1111/j.1346-8138.1990.tb03714.x. J Dermatol. 1990. PMID: 2158504
-
Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium.Endocrinology. 1994 Nov;135(5):1793-8. doi: 10.1210/endo.135.5.7956903. Endocrinology. 1994. PMID: 7956903
-
Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes.Arch Dermatol Res. 1997 May;289(6):367-72. doi: 10.1007/s004030050206. Arch Dermatol Res. 1997. PMID: 9209684
-
Vitamin D and epidermal differentiation: evidence for a role of endogenously produced vitamin D metabolites in keratinocyte differentiation.Skin Pharmacol. 1988;1(3):149-60. doi: 10.1159/000210769. Skin Pharmacol. 1988. PMID: 3078531 Review.
-
1,25(OH)2D3-modulated calcium induced keratinocyte differentiation.J Investig Dermatol Symp Proc. 1996 Apr;1(1):22-7. J Investig Dermatol Symp Proc. 1996. PMID: 9627687 Review.
Cited by
-
CYP27B1 Enzyme in Psoriasis: A Preliminary Study of Immunohistochemical Observations.Life (Basel). 2023 Dec 21;14(1):15. doi: 10.3390/life14010015. Life (Basel). 2023. PMID: 38276264 Free PMC article.
-
[New relevance of vitamin D3 metabolism in the skin].Hautarzt. 2004 May;55(5):446-52. doi: 10.1007/s00105-004-0727-2. Hautarzt. 2004. PMID: 15069602 Review. German.
-
Immunoreactivity of six monoclonal antibodies directed against 1,25-dihydroxyvitamin-D3 receptors in human skin.Histochem J. 2000 Oct;32(10):625-9. doi: 10.1023/a:1026748824945. Histochem J. 2000. PMID: 11202159
-
Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.Rev Endocr Metab Disord. 2016 Sep;17(3):405-417. doi: 10.1007/s11154-016-9353-4. Rev Endocr Metab Disord. 2016. PMID: 27447175 Review.
-
Effects of vitamin D and retinoic acid on human glioblastoma cell lines.Acta Neurochir (Wien). 1995;133(3-4):184-90. doi: 10.1007/BF01420072. Acta Neurochir (Wien). 1995. PMID: 8748764
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources